Acute Sarcopenia in Elderly with COVID-19: An Overlooked Problem

I. Gusti Putu Suka Aryana, Dian Daniella, Raden Ayu Tuty Kuswardhani, Siti Setiati

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)


The coronavirus Disease-19 (COVID-19) pandemic was announced in March 2020 by World Health Organization (WHO). Studies showed that the elderly had higher morbidity and mortality rates. Acute sarcopenia in the elderly with COVID-19 is an overlooked problem. Inflammation, malnutrition, immobilization, a side effect of COVID-19 treatment, depression, and hormonal dysregulation contributed to acute sarcopenia in COVID-19, especially in the elderly. Muscle quantity can be assessed with different techniques such as imaging or anthropometric measurements in diagnosing sarcopenia. Imaging such as CT scan was widely used in multiple studies. Still, anthropometric measurements are more fit in developing countries because they are widely available, safe, do not require special skills, and fit in low-resources facilities. Muscle strength can be assessed with grip strength. Acute sarcopenia was associated with immune dysregulation and cytokine storm, length of stay and readmission, and ICU admission and mechanical ventilation. These will contribute to high mortality in sarcopenic elderly with COVID-19.

Original languageEnglish
Pages (from-to)1269-1276
Number of pages8
JournalBali Medical Journal
Issue number3
Publication statusPublished - 1 Dec 2022


  • Covid-19
  • Elderly
  • Muscle Loss
  • Muscle mass
  • Sarcopenia


Dive into the research topics of 'Acute Sarcopenia in Elderly with COVID-19: An Overlooked Problem'. Together they form a unique fingerprint.

Cite this